Efficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials
- PMID: 26692005
- PMCID: PMC4761015
- DOI: 10.1007/s40261-015-0361-z
Efficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials
Abstract
Background: Iron deficiency is very common in a number of medical conditions. Ferric carboxymaltose is a new stable iron preparation that can be administered in single infusions over short periods of time. The aim of this study was to conduct a systematic review of randomised controlled trials (RCTs) regarding the efficacy and safety of the novel complex compared with other iron formulations. In addition, the feasibility of a network meta-analysis for indirect comparisons was investigated.
Methods: A systematic literature review was performed for published RCTs on the use of ferric carboxymaltose in iron deficiency between July and October 2014. Indirect comparisons were also addressed using terms referring to competing iron formulations. We further supported the qualitative results of the systematic review by a network meta-analysis that allows pooling the evidence around different intervention outcomes in the absence of trials involving a direct comparison.
Results: The initial search yielded 1027 citations, which was decreased to 21 studies eligible for inclusion in the review. Studies were heterogeneous in the number of patients randomised, iron deficiency-related conditions addressed, trial inclusion criteria, time horizon, treatment dosage and outcomes assessed. Six studies with the same time horizon (i.e. 6 weeks) were included in the network meta-analysis. Considering the differences between final and initial outcome values for each iron formulation, the mean difference of these differences (delta) was estimated for each couple of treatments involving ferric carboxymaltose. Significant improvements in serum ferritin (µg/l) were obtained with ferric carboxymaltose compared to oral iron (delta 172.8; 95 % CI 66.7-234.4) and in haemoglobin (g/dl) with respect to ferric gluconate (delta 0.6; 95 % CI 0.2-0.9), oral iron (delta 0.8; 95 % CI 0.6-0.9) and placebo (delta 2.1; 95 % CI 1.2-3.0).
Conclusions: All currently available intravenous iron preparations appear to be safe and effective, but ferric carboxymaltose seems to provide a better and quicker correction of haemoglobin and serum ferritin levels in iron-deficient patients.
Figures







Similar articles
-
Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis.Lancet Haematol. 2021 Jul;8(7):e503-e512. doi: 10.1016/S2352-3026(21)00137-X. Lancet Haematol. 2021. PMID: 34171281 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.Cochrane Database Syst Rev. 2016 Apr 13;4(4):CD011004. doi: 10.1002/14651858.CD011004.pub2. Cochrane Database Syst Rev. 2016. PMID: 27071857 Free PMC article.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
Cited by
-
Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study.J Clin Med. 2021 Mar 23;10(6):1322. doi: 10.3390/jcm10061322. J Clin Med. 2021. PMID: 33806864 Free PMC article.
-
Getting patient blood management Pillar 1 right in the Asia-Pacific: a call for action.Singapore Med J. 2020 Jun;61(6):287-296. doi: 10.11622/smedj.2019037. Epub 2019 May 2. Singapore Med J. 2020. PMID: 31044255 Free PMC article. Review.
-
Influence of mitochondrial and systemic iron levels in heart failure pathology.Heart Fail Rev. 2019 Sep;24(5):647-659. doi: 10.1007/s10741-019-09788-z. Heart Fail Rev. 2019. PMID: 31016425 Review.
-
The Impact of Iron Supplementation for Treating Anemia in Patients with Chronic Kidney Disease: Results from Pairwise and Network Meta-Analyses of Randomized Controlled Trials.Pharmaceuticals (Basel). 2020 Apr 30;13(5):85. doi: 10.3390/ph13050085. Pharmaceuticals (Basel). 2020. PMID: 32365757 Free PMC article.
-
Diagnosis and treatment of iron deficiency in chronic heart failure : Position statement of the heart failure working group of the Austrian Society of Cardiology.Wien Klin Wochenschr. 2025 Mar;137(Suppl 3):143-156. doi: 10.1007/s00508-025-02521-x. Epub 2025 May 6. Wien Klin Wochenschr. 2025. PMID: 40327072 Free PMC article.
References
-
- WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. World Health Organization, Geneva (WHO/NMH/NHD/MNM/11.1) (2011). http://www.who.int/vmnis/indicators/haemoglobin/en. Accessed 30th October 2015.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical